NCT06894901 is a NA clinical trial of Biological (Male Wolbachia-infected Aedes aegypti) in Dengue, sponsored by National Environment Agency, Singapore.

Who is sponsoring NCT06894901?

NCT06894901 is sponsored by National Environment Agency, Singapore.

What drugs are being tested in NCT06894901?

Interventions in NCT06894901: Biological (Male Wolbachia-infected Aedes aegypti).

Is NCT06894901 still recruiting?

NCT06894901 is currently recruiting now. Last updated 25 March 2025.

Last reviewed 2025-03-25 · How we verify

NCT06894901

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Impact of IIT-SIT on Dengue Clusters

Recruiting now NA Last updated 25 March 2025

What this trial tests

NA trial testing Biological (Male Wolbachia-infected Aedes aegypti) in Dengue in 900 participants. Currently enrolling.

Timeline

20 March 2025

Primary endpoint
20 July 2027

20 January 2028

Quick facts

Lead sponsor	National Environment Agency, Singapore
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	900
Start date	20 March 2025
Primary completion	20 July 2027
Estimated completion	20 January 2028
Sites	1 location across Singapore

Drugs / interventions tested

Biological (Male Wolbachia-infected Aedes aegypti) — full drug profile →

Conditions studied

Dengue — all drugs for Dengue →

Sponsor

National Environment Agency, Singapore

Who can join

Eligibility, any sex, with Dengue. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This randomized controlled trial aims to evaluate the efficacy of Wolbachia-infected male mosquitoes combined with sterile insect technique (IIT-SIT) to mitigate active dengue transmission in Singapore.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Biological (Male Wolbachia-infected Aedes aegypti)

Trials testing the same drug.

NCT05505682 — Impact of Project Wolbachia - Singapore on Dengue Incidence · NA · completed

Other recruiting trials for Dengue

Currently open trials in the same condition.

NCT07501793 — Demographic Characteristics of TAK-003 Dengue Vaccine Recipients in Vietnam · active not recruiting
NCT07358910 — Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective · recruiting
NCT07007585 — Risk Factors for Hospitalization and Transfusion Criteria in Patients With Dengue Virus Infection · recruiting
NCT07158190 — Evaluation of T-cell Responses After Vaccination With the Attenuated Tetravalent Dengue Vaccine (Takeda). · active not recruiting
NCT06599970 — Improving Disease Prevention Strategies by Integrating Socio-spatial Characterization of Human Mobility · recruiting

Other National Environment Agency, Singapore trials

Trials by the same sponsor.

NCT05505682 — Impact of Project Wolbachia - Singapore on Dengue Incidence · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06894901 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by National Environment Agency, Singapore
Last refreshed: 25 March 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06894901.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing